Are you a professional? Activate your profile
  • Financial advisor
  • Accountant
  • Lawyer
MoneyController
  • Find the advisor that's right for you
  • Are you a professional? Activate your profile
  • Financial advisor
  • Accountant
  • Lawyer
Are you already registered? Access Forgot your password?
  • Financial advisors
  • Calculation tools
    • Calculates the risk and return of a securities portfolio
    • Calculate your supplementary pension
  • News from the UK Stock Exchange
    • Finance forum
    • Finance webinar / Video
    • Latest news about the UK Stock Exchange
  • Funds / ETFs / Stock Ranking
    • Funds/ETFs Ranking
    • UK Stock Ranking
    • Best funds according to costs/risk/return
    • All Funds/ETFs (Product sheet and prospectus)
    • UK and International Stock List (Stock overview and news)
  • Learn about finance
    • Financial glossary
    • Learning to invest
      The most important concepts of finance
  • Study Office
    • Asset allocation
    • Finance app ranking
  • About us
    • About us
    • Comments
    • Contacts
Are you a professional?
Activate your profile

We apologise for any inconvenience.
from 18 on Saturday 28
to 12 on Sunday 29
it will not be possible to use the calculator
due to extraordinary maintenance.

We apologise for any inconvenience.
from 18 on Saturday 28
to 12 on Sunday 29
the PIC and PAC section will not be calculated
due to extraordinary maintenance.

  • Financial news
  • May 2025
Share

Financial news - May 2025 - news published 53.015 - readings 671.704

Select company / Select period
  • 2025
  • December
  • November
  • October
  • September
  • August
  • July
  • June
  • May
  • April
  • March
  • February
  • January
  • 2024
  • December
  • November
  • October
  • September
  • August
  • July
  • June
  • May
  • April
  • March
  • February
  • January
  • 2023
  • December
  • November
  • October
  • September
  • August
  • July
  • June
  • May
  • April
  • March
  • February
  • January
  • 2022
  • December
  • November
  • October
  • September
  • August
  • July
  • June
  • May
  • April
  • March
  • February
  • January
  • 2021
  • December
  • November
  • October
  • September
  • August
  • July
  • June
  • May
  • April
  • March
  • February
  • January

Youngtimers AG

Youngtimers AG

Postponement of publication of annual report 2024 until July 15, 2025, the latest, and potential postponement of annual general meeting

Ad hoc announcement pursuant to Art. 53 LR May 31, 2025, Basel, Switzerland - Youngtimers AG (SWX: YTME; the "Company") has submitted a second request to SIX Exchange Regulation AG ("SIX SER") to postpone the publication of the annual report 2024 and the filing of such report with SIX SER. The Company has requested an extension until July 15, 2025. The reas ...

Continue reading
31.05.2025
Leclanche SA

Leclanche SA

Leclanché announces filing of request to extend the publication dea...

Sat May 31 Ad hoc announcement pursuant to Art. 53 LR Leclanché will be unable to publish its 2024 annual report by 31 st May 2025, the initial extended deadline granted by SIX Exchange Regulation AG (SER) on 29 th April 2025. Leclanché has filed on time a request to extend the deadline for publishing its 2024 annual report until 30 th June 2025 but has not yet received the ...

Continue reading
31.05.2025
Meyer Burger Technology AG

Meyer Burger Technology AG

Meyer Burger files for insolvency for German subsidiaries

The German subsidiaries of Meyer Burger Technology AG, Meyer Burger (Industries) GmbH and Meyer Burger (Germany) GmbH, have each filed for insolvency proceedings. Intensive efforts were made to keep the sites open during the ongoing restructuring negotiations. These efforts have not been successful to date and will now be continued as part of the proceedings together with a pr ...

Continue reading
31.05.2025
ATM Grupa SA

ATM Grupa SA

Przemysław Kmiotek appointed CEO of ATM Grupa, Urszula Piasecka named Vice President

ATM Grupa has a new CEO! On May 30, 2025, the General Meeting of Shareholders appointed Przemysław Kmiotek, previously the company's Vice President, to the role. Kmiotek has been with ATM Grupa for over two decades. He began his career as a production assistant and went on to serve as Managing Director of the ATM Rozrywka channel, President of ATM Studio and ATM System, and, ...

Continue reading
31.05.2025
CPI Property Group SA

CPI Property Group SA

CPI Property Group – EGM 4 June 2025 Updated Draft Resolutions

CPI PROPERTY GROUP Société Anonyme 40, rue de la Vallée L-2661 Luxembourg R.C.S. L UXEMBOURG B 102254 (the "Company") UPDATED DRAFT RESOLUTIONS PROPOSED TO THE EXTRAORDINARY GENERAL MEETING OF THE SHAREHOLDERS OF THE COMPANY TO BE HELD ON 4 JUNE 2025 Dear Shareholders, Please find below updated draft resolutions that will be proposed to the shareholders at the ext ...

Continue reading
31.05.2025
Fourlis SA

Fourlis SA

Invitation to the Ordinary General Shareholders Meeting of 20.06.2025

FOURLIS HOLDINGS SOCIETE ANONYME Reg. No. in the G.C.R. (GEMI): 000258101000 (former Reg. No. in the Registry for SAs: 13110/06/B/86/01) INVITATION TO THE ANNUAL ORDINARY GENERAL ASSEMBLY OF SHAREHOLDERS By decision of the Board of Directors of the Company, in accordance with the Law and the Company's Articles of Association, Messrs. Shareholders are invited to the Ordinary Ge ...

Continue reading
31.05.2025
Smith & Nephew plc

Smith & Nephew plc

Investor Presentation April - July 2025

Investor Presentation April - July 2025 1856 Smith+Nephew established 1856-1896 Thomas James Smith opened a chemist shop in Hull, UK and develops a new method for refining cod liver oil. In 1896 Horatio Smith entered a partnership with his uncle forming TJ Smith & Nephew 1914 Days after the outbreak of WW1, we received an order to provide surgical and field dressing suppli ...

Continue reading
31.05.2025
Immatics NV

Immatics NV

IMA203 PRAME Cell Therapy Phase 1b Data in Patients with Metastatic Melanoma

IMA203 PRAME Cell Therapy in Advanced Melanoma - Phase 1b Dose Expansion Clinical Data Update May 31, 2025 Data cut-off April 7, 2025 Delivering the Power of T cells to Cancer Patients © Immatics. Not for further reproduction or distribution. Frequent recurrence and limited long-term survival with unresectable or metastatic melanoma highlight the critical need for new treatme ...

Continue reading
31.05.2025
Adagene Inc.

Adagene Inc.

2025 ASCO Data Presentation (8b9463)

2025 ASCO Data Presentation May 2025 Safety and Efficacy of ADG126 (an Anti-CTLA-4 Masking Antibody) in Combination with Pembrolizumab: Updated Results of Phase 1b/2 Study in Advanced MSS CRC Daneng Li 1 *, Sun Young Kim 2 *, Manish R. Patel 3 , Hee Kyung Kim 4 , Sunil Sharma 5 , Sang Joon Shin 6 , Jeeyun Lee 7 , Sae Won Han 8 , George Lau 9 , Brigette Ma 10 , Yan Li 11 , Song ...

Continue reading
31.05.2025
Immatics NV

Immatics NV

Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Immatics NV published this content on May 31, 2025 , and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT) , unedited and unaltered, on May 31, 2025 at 12:04 UTC .

Continue reading
31.05.2025
Immatics NV

Immatics NV

ASCO IMA203 PRAME Cell Therapy Phase 1b Data in Patients with Metastatic Melanoma

Phase 1 Clinical Update of IMA203, an Autologous TCR T Targeting PRAME in Patients with PD1 Refractory Metastatic Melanoma Martin Wermke 1 , Winfried Alsdorf 2 , Dejka M. Araujo 3 , Antonia Busse 4 , Manik Chatterjee 5 , Leonel Hernandez Aya 6 , Norbert Hilf 7 , Tobias A.W. Holderried 8 , Amir A. Jazaeri 3 , M. Alper Kursunel 7 , Andrea Mayer-Mokler 7 , Regina Mendrzyk 7 , Ali ...

Continue reading
31.05.2025
Sarepta Therapeutics Inc.

Sarepta Therapeutics Inc.

P1350 Mendell et al Pooled Analyses 3 year vs EC

3-Year Functional Outcomes of Patients With Duchenne Muscular Dystrophy: Pooled Delandistrogene Moxeparvovec Clinical Trial Data vs External Controls Jerry Mendell 1 ; Anne M. Connolly 2 ; John Day 3 ; Craig McDonald 4 ; Crystal Proud 5 ; Perry Shieh 6 ; Craig Zaidman 7 ; Matthew Furgerson 1 ; Sravya Ennamuri 1 ; Kai Ding 1 ; Carol Reid 8 ; Alexander P. Murphy 8 ; Louise Rodin ...

Continue reading
31.05.2025
Sarepta Therapeutics Inc.

Sarepta Therapeutics Inc.

P1422 Baine et al SRP 9003 RNAscope

‌#1422 In Situ Biodistribution and Localization of Bidridistrogene Xeboparvovec (SRP-9003) in LGMD2E/R4 Mice After 1 Year of Follow-up Stephen Baine, Young Seo, Stephen Fasul , Jenna Greve, Chrissy Hopkins, Akansha Pradhan, Jasmine Wu, Alex Haile, Sarah Lewis, Louise Rodino-Klapac, Rachael Potter Sarepta Therapeutics, Inc., Cambridge, MA, USA Introduction Limb-girdle muscula ...

Continue reading
31.05.2025
Alstom SA

Alstom SA

Alstom inaugurates first service depot in Shu, Kazakhstan, creating 100 jobs and driving regional growth

Download as PDF Press contact - Western and Central Asia Aizhan Aldabergenova Send an email Attachments Original document Permalink Disclaimer Alstom SA published this content on May 31, 2025 , and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT) , unedited and unaltered, on May 31, 2025 at 11:16 UTC .

Continue reading
31.05.2025
Pitney Bowes Inc.

Pitney Bowes Inc.

Q1 2025 Financial Schedules

Pitney Bowes Inc. Consolidated Statements of Operations (Unaudited; in thousands, except per share amounts) Three months ended March 31 2025 2024 Revenue: Services $ 318,432 $ 322,690 Products 93,190 114,124 Financing and Other 81,798 84,455 Total revenue 493,420 521,269 Costs and expenses: Cost of services 155,873 Cost of products 50,919 Cost of financing and other 17,507 Sel ...

Continue reading
31.05.2025
  • 1
  • 2
  • 3
  • >>
  • 10
OUR CUSTOMERS T.Rowe Franklin Templeton WisdomTree Pimco Anima iShares MFS Nordea AXA Pictet OnlineSIM SoldiExpert Citywire Framont Opstart MoneyFarm Invesco Fidelity Lyxor Consultique Tokos Avatrade Alfa Borsa del credito
MoneyController Srl
Registered office
Via Stazione, 9/B
26013 Crema (CR) - Italy
P.IVA: 05937430485
info@moneycontroller.it
www.moneycontroller.it

About us

Comments
Contacts

Privacy and Cookie Policy
Terms and conditions

Website
  • www.moneycontroller.co.uk
Contact
  • info@moneycontroller.it
Website
  • www.moneycontroller.co.uk
Contact
  • info@moneycontroller.it
FINANCIAL ADVISORS
  • Publish your profile
  • Search by location
  • Search by company
FINANCIAL ADVISORS
  • Publish your profile
  • Search by location
  • Search by company

Registered in the Press Register Court of Milan no. 193 by resolution of 25/07/2016
is a registered trademark
Follow us on
  • Facebook
  • Instagram
  • Linkedin
  • Twitter

Write a comment
help us to improve our services

Read the reviews

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

€2,99per month

Discover all the advantages of the offer
Become
Member

€2,99per month

Discover all the advantages of the offer